DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Sheingold SH, Churchill DN, Muirhead N, Laupacis A.
Recombinant human erythropoietin: factors to consider in cost-benefit analysis.
Am J Kidney Dis 1991;
17 (01) 86-92
We do not assume any responsibility for the contents of the web pages of other providers.